.Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AA31_Bamethan.Bamethan .Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AA31_Bamethan.Bamethan| name: | Bamethan | |
| ATC code: | C04AA31 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 50 | mg |
| volume of distribution: | 2.5 | L |
| clearance: | 120 | mL/min |
| other parameters in model implementation | ||
Bamethan is a vasodilator drug that has been used for the treatment of peripheral vascular disorders such as Raynaud's disease and arterial circulatory disorders. It is a sympathomimetic amine structurally related to amphetamine. Bamethan has limited contemporary clinical use and is not widely approved or used in modern medicine.
No published pharmacokinetic studies were found for bamethan in humans or animals. The following values are estimations based on general characteristics of orally administered amphetamine-like sympathomimetics in adult healthy individuals.